Systemic alpha-interferon therapy of multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Systemic alpha-interferon therapy of multiple sclerosis.

Systemic alpha-interferon therapy of multiple sclerosis.

http://www.wikidata.org/entity/Q41418423

about

Interferons at age 50: past, current and future impact on biomedicine Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.Assessing changes in relapse rates in multiple sclerosis.How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.Sweet tooth maketh a sour disposition.Interferon in relapsing-remitting multiple sclerosis.DNA length polymorphism located 5' to the human myelin basic protein gene.Development of interferon-beta as a therapy for multiple sclerosis.Interferon beta and glatiramer acetate therapy.Effects of experimental recombinant interferons on multiple sclerosis.Immunotherapy for multiple sclerosis.Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results.Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.Update on the use of biologics in primary systemic vasculitides.The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis: An example of Occam's Broom?Interferons in the central nervous system: a few instruments play many tunes.Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy.Immunotherapy of multiple sclerosis.Interferon beta for multiple sclerosis.Interferon inhibitor factor predicting success of plasmapheresis in patients with multiple sclerosis.Investigational drug therapies of treatment of multiple sclerosis.Cortisol induction by poly ICLC: implications for clinical trials of interferon.Use of interferon in multiple sclerosis.Multiple sclerosis: involvement of interferons in lesion pathogenesis.Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up

P2860

Q28259312-D6034CCA-CB44-4EE1-9417-90A4E04DB8F9 Q33194284-0F2474CF-3660-4EA8-9041-27BDDA57BE11 Q33560305-B954504F-1177-4CCA-9496-D77F17C470E5 Q33681680-918A5DD9-2F1A-46A4-A022-C596B2F77708 Q33988240-BE494B95-D9BB-46FE-96E7-54F95499BCD2 Q34287211-B4EC0ACB-66A1-43BE-A7C3-2CFD87F22C61 Q34424659-C0E9B6F1-98F2-402F-BDFA-F5C08547410B Q35199064-0E18789D-5903-48F5-9F06-7EA4FC78EEC2 Q35967412-46FC26EC-A94A-4C07-9607-EF9BABEF3D0D Q36568660-D8FC6985-6DD5-4823-B6BE-271FAD7A87B4 Q36646949-878C2228-827C-4DEF-A1E0-9FB73859C58A Q36850073-51235E37-F9EF-441A-A283-B88D6EB1DBA0 Q36938442-6D1CA06A-C126-4965-8FB5-1832968A462B Q37468752-34378A3B-9DF5-4596-9843-690D6745B49E Q37754811-CF339A31-710E-4521-A102-0A3B6E9B1F3A Q38177822-D3C2973F-2935-4CDE-82C4-537C0441FC57 Q38192651-A7BCC95A-728E-488E-AB93-30A59939D608 Q39153032-47F11B0F-C6A4-4771-89B7-ABC64768EE83 Q39644393-476F6D9D-6FC4-445B-869B-B8E62D4D28B0 Q40693727-91BB8A14-4D9A-4365-A484-6045B5E9ECE0 Q41505309-EC471F80-1E1A-4F4A-8AAD-C651AEBC6F91 Q41622019-6B0CF55C-6A60-4DDF-9DF6-250C22ECE62D Q41809012-8CD28890-5D97-45C4-A3DE-22BB91889DAF Q43630468-E7B7072D-E6FA-45FD-815C-C62E7512EDC0 Q44269218-4677909C-E65E-4C39-9E97-73C64FED7C9C Q57912093-8A047EC9-E117-41DF-B22B-997DE6AF2A73

P2860

Systemic alpha-interferon therapy of multiple sclerosis.

http://www.wikidata.org/entity/Q41418423

description

1984 nî lūn-bûn

@nan

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

1984年论文

@zh

1984年论文

@zh-cn

name

Systemic alpha-interferon therapy of multiple sclerosis.

@en

type

label

Systemic alpha-interferon therapy of multiple sclerosis.

@en

prefLabel

Systemic alpha-interferon therapy of multiple sclerosis.

@en

P1433

Q41418423-D93D979B-1AA0-4862-86BF-B9CAFC9A5851

P1476

Q41418423-C0348383-5B94-4731-862B-DD91E5A618AF

P2093

Q41418423-0F500A32-F479-46DD-9B4C-2CC008433596

Q41418423-21A0FB20-2F10-42B1-A502-75A1881D9DCC

Q41418423-31BC14C1-8AAF-4A4F-8B85-A7CEABB191E4

Q41418423-524F91ED-3E42-4EDE-BF18-CF2B15CE432A

Q41418423-5AA7C0A7-E074-4108-9453-FC3E2BE8A6C3

Q41418423-610180A0-97E5-4641-BAB9-118787F90C0A

Q41418423-783F4E2A-5784-47CE-B9DE-71F454C3A94B

Q41418423-87A43B5B-625D-429F-B3A3-3753951CC255

Q41418423-89D5958B-E8E8-4D57-8482-529970691A38

Q41418423-D837F77E-4410-440A-A64B-10C8091A9917

P304

Q41418423-166D64FA-7A21-4062-9A54-65CE374CD9C3

P31

Q41418423-51B31405-3E8F-47B6-AD7F-C33F84FBEB5D

P356

Q41418423-8CC8BFEF-29C1-403B-B54C-E64DA11FEAF1

P407

Q41418423-2EBA2970-95E5-4033-8261-39252B6793FB

P433

Q41418423-D7DFE1F7-F364-489F-9530-4A2B07569CA3

P478

Q41418423-85ADC79F-83A6-4F81-A051-ED3057D32BF9

P577

Q41418423-AD5B37A3-1E43-41E4-94C7-9D0431B77CD9

P698

Q41418423-8B95C508-8BF9-45A2-A147-8314EBD2AE33

P921

Q41418423-0BC16884-4CFF-469D-BCFE-D6AA6A7C1ED0

P356

P1433

P1476

Systemic alpha-interferon therapy of multiple sclerosis.

@en

P2093

Braheny SL

http://www.w3.org/2001/XMLSchema#string

Francis GS

http://www.w3.org/2001/XMLSchema#string

Hooper CK

http://www.w3.org/2001/XMLSchema#string

Huddlestone JR

http://www.w3.org/2001/XMLSchema#string

Johnson KP

http://www.w3.org/2001/XMLSchema#string

Kamin-Lewis RM

http://www.w3.org/2001/XMLSchema#string

Knobler RL

http://www.w3.org/2001/XMLSchema#string

Panitch HS

http://www.w3.org/2001/XMLSchema#string

Rice GP

http://www.w3.org/2001/XMLSchema#string

Sipe JC

http://www.w3.org/2001/XMLSchema#string

P304

1273-1279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.34.10.1273

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

1984-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6384817

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis